Transition cAre inteRvention tarGeted to High-risk patiEnts To Reduce rEADmission

NCT03496896 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
1393
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Insel Gruppe AG, University Hospital Bern

Collaborators